Anti-proinflammatory effects of sirolimus on human islet preparations.
about
Emerging role of chemokine CC motif ligand 4 related mechanisms in diabetes mellitus and cardiovascular disease: friends or foes?Adenosine A(2A) agonist administration improves islet transplant outcome: Evidence for the role of innate immunity in islet graft rejection.Oral rapamycin attenuates inflammation and enhances stability of atherosclerotic plaques in rabbits independent of serum lipid levels.Prolactin supplementation to culture medium improves beta-cell survival.Treatment with Tacrolimus and Sirolimus Reveals No Additional Adverse Effects on Human Islets In Vitro Compared to Each Drug Alone but They Are Reduced by Adding Glucocorticoids.Antiproinflammatory effects of iodixanol (OptiPrep)-based density gradient purification on human islet preparations.Evidence for rapamycin toxicity in pancreatic β-cells and a review of the underlying molecular mechanisms.Use of additives, scaffolds and extracellular matrix components for improvement of human pancreatic islet outcomes in vitro: A systematic review.Implication of mitochondrial cytoprotection in human islet isolation and transplantation.The sequential combination of a JNK inhibitor and simvastatin protects porcine islets from peritransplant apoptosis and inflammation.Improved human islet preparations using glucocorticoid and exendin-4.Enhancement of in vitro and in vivo function of agarose-encapsulated porcine islets by changes in the islet microenvironment.Different effects of FK506, rapamycin, and mycophenolate mofetil on glucose-stimulated insulin release and apoptosis in human islets.
P2860
Q26739691-87609F2F-0ACB-4DE7-A1C7-81E0F7DEF33AQ30450509-426B6A3A-48A3-4567-BD44-4CB7F0552177Q30482901-548FC7BD-6A70-4395-AE00-C9136A1452C4Q33548278-E845C57D-55A4-48B5-B48A-1C4D89184DD4Q36538911-2F00A77B-68C8-418C-85AB-1C5E66E12B96Q37183811-F4691A0A-7143-4865-89CA-6F0A362D9A96Q38123696-20503E72-06F7-4215-AB14-09FE010DDEF2Q38692970-47A15406-30C2-4C4A-BF4B-6F6F720AECD9Q41770952-C1168C9B-C330-4CAC-923D-C4D6D4E80555Q42774205-D90A45A1-9500-43A1-9C6B-8B14B6CFF532Q42957118-594A2FB3-EE92-43B5-8193-F16CA2C6DFA6Q45941829-3BF56D50-1EDD-436F-982C-A09B0CF95818Q45981052-0F9A49B0-94A6-4DF1-BF2D-3E5BDF63B348
P2860
Anti-proinflammatory effects of sirolimus on human islet preparations.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Anti-proinflammatory effects of sirolimus on human islet preparations.
@en
Anti-proinflammatory effects of sirolimus on human islet preparations.
@nl
type
label
Anti-proinflammatory effects of sirolimus on human islet preparations.
@en
Anti-proinflammatory effects of sirolimus on human islet preparations.
@nl
prefLabel
Anti-proinflammatory effects of sirolimus on human islet preparations.
@en
Anti-proinflammatory effects of sirolimus on human islet preparations.
@nl
P2093
P2860
P1433
P1476
Anti-proinflammatory effects of sirolimus on human islet preparations.
@en
P2093
Atsushi Miki
Atsuyoshi Mita
George W Burke
Luca Inverardi
Ross Haertter
Scott Barker
Shin-Ichi Miyagawa
Yasuhiko Hashikura
P2860
P356
10.1097/TP.0B013E31817C79C0
P577
2008-07-01T00:00:00Z